vs

Side-by-side financial comparison of Torrid Holdings Inc. (CURV) and Tarsus Pharmaceuticals, Inc. (TARS). Click either name above to swap in a different company.

Torrid Holdings Inc. is the larger business by last-quarter revenue ($235.2M vs $151.7M, roughly 1.6× Tarsus Pharmaceuticals, Inc.). Torrid Holdings Inc. runs the higher net margin — -2.7% vs -5.5%, a 2.8% gap on every dollar of revenue. On growth, Tarsus Pharmaceuticals, Inc. posted the faster year-over-year revenue change (128.4% vs -10.8%). Tarsus Pharmaceuticals, Inc. produced more free cash flow last quarter ($13.0M vs $-6.6M). Over the past eight quarters, Tarsus Pharmaceuticals, Inc.'s revenue compounded faster (134.4% CAGR vs -10.5%).

Torrid Holdings Inc. is an American women's retail chain formerly owned by Hot Topic. While it is still owned by Sycamore Partners, owners of Hot Topic, in 2015, the company branched off to become Torrid, LLC. The store offers plus-size clothing and accessories for women size 10-30. Torrid began operations in April 2001. The first location opened in the Brea Mall in Brea, California. As of 2024, Torrid has over 650 stores in operation across all states in the United States and some regions of...

Tarsus Pharmaceuticals, Inc. is a late-stage clinical biopharmaceutical company focused on developing and commercializing innovative therapeutic candidates for unmet medical needs in ophthalmology, dermatology, and other specialty care areas. It operates primarily in the United States, with lead product candidates targeting common, underdiagnosed conditions including demodex blepharitis and rosacea.

CURV vs TARS — Head-to-Head

Bigger by revenue
CURV
CURV
1.6× larger
CURV
$235.2M
$151.7M
TARS
Growing faster (revenue YoY)
TARS
TARS
+139.2% gap
TARS
128.4%
-10.8%
CURV
Higher net margin
CURV
CURV
2.8% more per $
CURV
-2.7%
-5.5%
TARS
More free cash flow
TARS
TARS
$19.6M more FCF
TARS
$13.0M
$-6.6M
CURV
Faster 2-yr revenue CAGR
TARS
TARS
Annualised
TARS
134.4%
-10.5%
CURV

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
CURV
CURV
TARS
TARS
Revenue
$235.2M
$151.7M
Net Profit
$-6.4M
$-8.4M
Gross Margin
34.9%
Operating Margin
0.1%
-5.3%
Net Margin
-2.7%
-5.5%
Revenue YoY
-10.8%
128.4%
Net Profit YoY
-438.2%
63.8%
EPS (diluted)
$-0.06
$-0.17

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CURV
CURV
TARS
TARS
Q4 25
$235.2M
$151.7M
Q3 25
$262.8M
$118.7M
Q2 25
$266.0M
$102.7M
Q1 25
$275.6M
$78.3M
Q4 24
$263.8M
$66.4M
Q3 24
$284.6M
$48.1M
Q2 24
$279.8M
$40.8M
Q1 24
$293.5M
$27.6M
Net Profit
CURV
CURV
TARS
TARS
Q4 25
$-6.4M
$-8.4M
Q3 25
$1.6M
$-12.6M
Q2 25
$5.9M
$-20.3M
Q1 25
$-3.0M
$-25.1M
Q4 24
$-1.2M
$-23.1M
Q3 24
$8.3M
$-23.4M
Q2 24
$12.2M
$-33.3M
Q1 24
$-4.1M
$-35.7M
Gross Margin
CURV
CURV
TARS
TARS
Q4 25
34.9%
Q3 25
35.6%
Q2 25
38.1%
Q1 25
33.6%
Q4 24
36.1%
Q3 24
38.7%
Q2 24
41.3%
Q1 24
34.5%
Operating Margin
CURV
CURV
TARS
TARS
Q4 25
0.1%
-5.3%
Q3 25
3.9%
-12.2%
Q2 25
6.0%
-21.6%
Q1 25
1.3%
-33.5%
Q4 24
2.7%
-36.8%
Q3 24
7.2%
-52.3%
Q2 24
9.3%
-81.6%
Q1 24
1.4%
-136.5%
Net Margin
CURV
CURV
TARS
TARS
Q4 25
-2.7%
-5.5%
Q3 25
0.6%
-10.6%
Q2 25
2.2%
-19.8%
Q1 25
-1.1%
-32.1%
Q4 24
-0.5%
-34.8%
Q3 24
2.9%
-48.7%
Q2 24
4.4%
-81.6%
Q1 24
-1.4%
-129.4%
EPS (diluted)
CURV
CURV
TARS
TARS
Q4 25
$-0.06
$-0.17
Q3 25
$0.02
$-0.30
Q2 25
$0.06
$-0.48
Q1 25
$-0.04
$-0.64
Q4 24
$-0.01
$-0.57
Q3 24
$0.08
$-0.61
Q2 24
$0.12
$-0.88
Q1 24
$-0.03
$-1.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CURV
CURV
TARS
TARS
Cash + ST InvestmentsLiquidity on hand
$17.2M
$417.3M
Total DebtLower is stronger
$276.4M
$72.4M
Stockholders' EquityBook value
$-206.5M
$343.4M
Total Assets
$402.9M
$562.2M
Debt / EquityLower = less leverage
0.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CURV
CURV
TARS
TARS
Q4 25
$17.2M
$417.3M
Q3 25
$21.5M
$401.8M
Q2 25
$23.7M
$381.1M
Q1 25
$48.5M
$407.9M
Q4 24
$44.0M
$291.4M
Q3 24
$53.9M
$317.0M
Q2 24
$20.5M
$323.6M
Q1 24
$11.7M
$298.5M
Total Debt
CURV
CURV
TARS
TARS
Q4 25
$276.4M
$72.4M
Q3 25
$280.5M
$72.3M
Q2 25
$284.5M
$72.1M
Q1 25
$288.6M
$72.0M
Q4 24
$71.8M
Q3 24
$71.7M
Q2 24
$71.6M
Q1 24
$29.9M
Stockholders' Equity
CURV
CURV
TARS
TARS
Q4 25
$-206.5M
$343.4M
Q3 25
$-201.1M
$335.1M
Q2 25
$-183.8M
$332.6M
Q1 25
$-191.1M
$342.5M
Q4 24
$-189.3M
$224.5M
Q3 24
$-188.9M
$237.5M
Q2 24
$-198.6M
$252.2M
Q1 24
$-211.7M
$275.2M
Total Assets
CURV
CURV
TARS
TARS
Q4 25
$402.9M
$562.2M
Q3 25
$414.5M
$534.6M
Q2 25
$451.4M
$495.0M
Q1 25
$488.4M
$500.8M
Q4 24
$493.0M
$377.0M
Q3 24
$487.5M
$376.3M
Q2 24
$479.7M
$376.8M
Q1 24
$476.9M
$349.3M
Debt / Equity
CURV
CURV
TARS
TARS
Q4 25
0.21×
Q3 25
0.22×
Q2 25
0.22×
Q1 25
0.21×
Q4 24
0.32×
Q3 24
0.30×
Q2 24
0.28×
Q1 24
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CURV
CURV
TARS
TARS
Operating Cash FlowLast quarter
$-4.9M
$19.3M
Free Cash FlowOCF − Capex
$-6.6M
$13.0M
FCF MarginFCF / Revenue
-2.8%
8.6%
Capex IntensityCapex / Revenue
0.7%
4.2%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-2.3M
$-22.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CURV
CURV
TARS
TARS
Q4 25
$-4.9M
$19.3M
Q3 25
$15.7M
$18.3M
Q2 25
$-18.0M
$-29.4M
Q1 25
$12.0M
$-20.7M
Q4 24
$-3.1M
$-22.2M
Q3 24
$40.8M
$-8.7M
Q2 24
$27.6M
$-14.4M
Q1 24
$9.0M
$-37.8M
Free Cash Flow
CURV
CURV
TARS
TARS
Q4 25
$-6.6M
$13.0M
Q3 25
$14.6M
$16.3M
Q2 25
$-20.6M
$-30.4M
Q1 25
$10.2M
$-21.2M
Q4 24
$-5.5M
$-22.3M
Q3 24
$37.7M
$-8.9M
Q2 24
$20.6M
$-15.4M
Q1 24
$-1.7M
$-38.0M
FCF Margin
CURV
CURV
TARS
TARS
Q4 25
-2.8%
8.6%
Q3 25
5.6%
13.8%
Q2 25
-7.7%
-29.6%
Q1 25
3.7%
-27.1%
Q4 24
-2.1%
-33.5%
Q3 24
13.2%
-18.6%
Q2 24
7.4%
-37.8%
Q1 24
-0.6%
-137.5%
Capex Intensity
CURV
CURV
TARS
TARS
Q4 25
0.7%
4.2%
Q3 25
0.4%
1.6%
Q2 25
1.0%
1.0%
Q1 25
0.6%
0.8%
Q4 24
0.9%
0.1%
Q3 24
1.1%
0.6%
Q2 24
2.5%
2.5%
Q1 24
3.7%
0.6%
Cash Conversion
CURV
CURV
TARS
TARS
Q4 25
Q3 25
10.05×
Q2 25
-3.03×
Q1 25
Q4 24
Q3 24
4.90×
Q2 24
2.27×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CURV
CURV

Apparel$213.6M91%
Non Apparel$12.3M5%
Other$9.2M4%
Loyalty Program$1.1M0%

TARS
TARS

Segment breakdown not available.

Related Comparisons